Kingswood Wealth Advisors LLC Sells 818 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Kingswood Wealth Advisors LLC trimmed its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.0% in the first quarter, according to its most recent filing with the SEC. The fund owned 5,032 shares of the exchange traded fund’s stock after selling 818 shares during the period. Kingswood Wealth Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $477,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of the company. Parkside Investments LLC lifted its stake in shares of SPDR S&P Biotech ETF by 11.1% in the 1st quarter. Parkside Investments LLC now owns 93,752 shares of the exchange traded fund’s stock valued at $8,896,000 after acquiring an additional 9,395 shares during the last quarter. Beech Hill Advisors Inc. increased its holdings in SPDR S&P Biotech ETF by 33.3% in the first quarter. Beech Hill Advisors Inc. now owns 6,468 shares of the exchange traded fund’s stock valued at $614,000 after purchasing an additional 1,616 shares during the period. Worth Asset Management LLC acquired a new stake in SPDR S&P Biotech ETF in the first quarter valued at $1,194,000. Ignite Planners LLC acquired a new stake in SPDR S&P Biotech ETF in the first quarter valued at $247,000. Finally, Harbor Investment Advisory LLC increased its holdings in SPDR S&P Biotech ETF by 304.6% in the first quarter. Harbor Investment Advisory LLC now owns 9,297 shares of the exchange traded fund’s stock valued at $882,000 after purchasing an additional 6,999 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.7 %

NYSEARCA XBI opened at $92.82 on Friday. The company has a market capitalization of $7.07 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The stock has a fifty day simple moving average of $89.75 and a 200 day simple moving average of $90.63.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.